Samye Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 20-05-2024
- Paid Up Capital ₹ 0.10 M
as on 20-05-2024
- Company Age 5 Year, 7 Months
- Last Filing with ROC 31 Mar 2023
About Samye Pharmaceuticals
The Company is engaged in the Chemicals Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Ningma Doma, Tashi Wangdi, and Atul Jain serve as directors at the Company.
- CIN/LLPIN
U24230DL2019PTC350275
- Company No.
350275
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
21 May 2019
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
South West Delhi, Delhi, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Samye Pharmaceuticals?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ningma Doma  | Director | 21-May-2019 | Current |
| Tashi Wangdi | Director | 21-May-2019 | Current |
| Atul Jain | Director | 21-May-2019 | Current |
Financial Performance of Samye Pharmaceuticals.
Samye Pharmaceuticals Private Limited, for the financial year ended 2020, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Samye Pharmaceuticals?
Unlock access to Samye Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Aauracare Pharmaceutical Private LimitedActive 13 years 7 monthsNingma Doma, Tashi Wangdi and 1 more are mutual person
Samye Consumers Products Private LimitedActive 4 years 6 monthsNingma Doma and Atul Jain are mutual person
- Aauracare Healthcare Private LimitedActive 1 year 10 months
Ningma Doma and Atul Jain are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Samye Pharmaceuticals?
Unlock and access historical data on people associated with Samye Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Samye Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Samye Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
